Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.33
-0.06
(-1.11%)
At close: 4:00:01 PM EDT
5.34
+0.01
+(0.19%)
After hours: 6:03:13 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Daniel J. Luckshire CPA, M.B.A. | Executive VP, CFO & Secretary | 1.42M | -- | 1971 |
| Dr. Dennis E. Hruby Ph.D. | Executive VP & Chief Scientific Officer | 1.41M | -- | 1952 |
| Dr. Diem Nguyen M.B.A., Ph.D. | CEO & Director | -- | -- | 1973 |
| Ms. Tove C. Bolken | Senior VP of Operations & Chief Supply Chain Officer | -- | -- | -- |
| Mr. Herb Vloedman | Senior VP & Chief Information Officer | -- | -- | -- |
| Mr. Lawrence R. Miller Esq., J.D. | General Counsel | -- | -- | 1969 |
SIGA Technologies, Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 46
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. The company's lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Corporate Governance
SIGA Technologies, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 7. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 2; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 5, 2025 at 8:00 PM UTC - May 9, 2025 at 8:00 PM UTC
SIGA Technologies, Inc. Earnings Date
Recent Events
Related Tickers
EBS Emergent BioSolutions Inc.
4.4400
-1.77%
ANIK Anika Therapeutics, Inc.
13.92
-0.64%
COLL Collegium Pharmaceutical, Inc.
27.38
-2.70%
LNTH Lantheus Holdings, Inc.
95.45
+4.98%
ACUR Acura Pharmaceuticals, Inc.
0.0198
+1,000.00%
AMPH Amphastar Pharmaceuticals, Inc.
25.00
-6.05%
IRWD Ironwood Pharmaceuticals, Inc.
1.2700
-5.22%
SNOA Sonoma Pharmaceuticals, Inc.
1.9100
-5.45%
EVOK Evoke Pharma, Inc.
2.3500
+5.86%
ASRT Assertio Holdings, Inc.
0.5884
-6.19%